ArticleCureus2026
Two Decades of Endocrine Silence: Severe Hyponatremia Presenting as Late-Onset Sheehan Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sheehan syndrome is a rare but potentially fatal complication of postpartum hemorrhage caused by ischemic necrosis of the anterior pituitary gland. Although its incidence has decreased in countries with comprehensive obstetric care systems, it remains a significant cause of panhypopituitarism in regions lacking timely and adequate access to perinatal care. The clinical challenge lies in its insidious presentation: symptoms develop slowly and gradually, and the diagnosis may remain unrecognized for decades. We report the case of a 52-year-old woman who presented with a one-year history of progressive decline in general health, characterized by debilitating asthenia, somnolence, decreased appetite, and an unintentional 13-kg weight loss. Her obstetric history provided the crucial diagnostic clue: 21 years prior, her last delivery - an initially unattended home birth - was complicated by a retained placenta and severe hemorrhage, followed by total agalactia and permanent secondary amenorrhea. Initial laboratory evaluation revealed severe hyponatremia (119 mmol/L), normocytic anemia, and biochemical evidence of central hypothyroidism and adrenal insufficiency. Magnetic resonance imaging (MRI) confirmed an empty sella turcica. Sequential hormone replacement therapy was initiated - administering glucocorticoids before levothyroxine - resulting in the normalization of serum sodium levels and significant clinical improvement. The clinical triad of postpartum hemorrhage, agalactia, and secondary amenorrhea constitutes a critical diagnostic red flag. Timely recognition of Sheehan syndrome is essential not only for resolving acute complications such as hyponatremia, driven by secondary hypothyroidism and hypocortisolism, but also for preventing cardiometabolic complications and severe osteoporosis with a high fracture risk associated with untreated chronic hypopituitarism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.